Gilead Sciences has said it will soon start a clinical trial in Europe of its twice-yearly HIV injection Sunlenca for pre-exposure prophylaxis (PrEP), a potential successo
Centred on digital health and economics, Day Two of the Future of Health summit kicks off post a slightly earlier welcome with the panel, ‘Addressing the healthcare workforce crisis’.
Centred on its main themes of sustainability, inclusivity, and digital health, Day One of the Future of Health summit kicks off post-welcome with a panel: ‘Partnering to build resilient and sust
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS